Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19224751 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Phase I Study of Ad5-hGCC (Human Guanylyl Cyclase C)-PADRE in Stage I/II Colon Cancer
Condition: Colon Cancer
Intervention: Biological: Ad5-hGCC-PADRE vaccine

Indicates status has not been verified in more than two years